-
1
-
-
0037696629
-
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
-
Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, et al. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003; 107:2238-2243.
-
(2003)
Circulation
, vol.107
, pp. 2238-2243
-
-
Zhou, Z.1
Wang, K.2
Penn, M.S.3
Marso, S.P.4
Lauer, M.A.5
Forudi, F.6
-
2
-
-
0037380608
-
Central role of RAGE-dependent neointimal expansion in arterial restenosis
-
Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003; 111:959-972.
-
(2003)
J Clin Invest
, vol.111
, pp. 959-972
-
-
Sakaguchi, T.1
Yan, S.F.2
Yan, S.D.3
Belov, D.4
Rong, L.L.5
Sousa, M.6
-
3
-
-
14044268796
-
Atherosclerosis and restenosis: Is there a role for RAGE?
-
Nawroth P, Bierhaus A, Marrero M, Yamamoto H, Stern DM. Atherosclerosis and restenosis: is there a role for RAGE? Curr Diab Rep 2005; 5:11-16.
-
(2005)
Curr Diab Rep
, vol.5
, pp. 11-16
-
-
Nawroth, P.1
Bierhaus, A.2
Marrero, M.3
Yamamoto, H.4
Stern, D.M.5
-
4
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/ calgranulin polypeptides
-
Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell 1999; 97:889-901.
-
(1999)
Cell
, vol.97
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
Qu, W.4
Taguchi, A.5
Lu, Y.6
-
5
-
-
0028979597
-
N-epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
-
Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N-epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995; 34:10872-10878.
-
(1995)
Biochemistry
, vol.34
, pp. 10872-10878
-
-
Reddy, S.1
Bichler, J.2
Wells-Knecht, K.J.3
Thorpe, S.R.4
Baynes, J.W.5
-
6
-
-
0029665694
-
-
Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, et al. N-(epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35:8075-8083.
-
Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, et al. N-(epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35:8075-8083.
-
-
-
-
7
-
-
0030763201
-
Increased accumulation of the glycoxidation product N-(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging
-
Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N-(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997; 99:457-468.
-
(1997)
J Clin Invest
, vol.99
, pp. 457-468
-
-
Schleicher, E.D.1
Wagner, E.2
Nerlich, A.G.3
-
8
-
-
0032588929
-
N-(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress
-
Nerlich AG, Schleicher ED. N-(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress. Atherosclerosis 1999; 144:41-47.
-
(1999)
Atherosclerosis
, vol.144
, pp. 41-47
-
-
Nerlich, A.G.1
Schleicher, E.D.2
-
9
-
-
0029923574
-
The advanced glycation end product, N-epsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions
-
Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, N-epsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996; 271:9982-9986.
-
(1996)
J Biol Chem
, vol.271
, pp. 9982-9986
-
-
Fu, M.X.1
Requena, J.R.2
Jenkins, A.J.3
Lyons, T.J.4
Baynes, J.W.5
Thorpe, S.R.6
-
10
-
-
0032694683
-
The myeloperoxidase system of human phagocytes generates N-epsilon- (carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation
-
Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates N-epsilon- (carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999; 104:103-113.
-
(1999)
J Clin Invest
, vol.104
, pp. 103-113
-
-
Anderson, M.M.1
Requena, J.R.2
Crowley, J.R.3
Thorpe, S.R.4
Heinecke, J.W.5
-
11
-
-
0037180531
-
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
-
Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002; 106:2827-2835.
-
(2002)
Circulation
, vol.106
, pp. 2827-2835
-
-
Bucciarelli, L.G.1
Wendt, T.2
Qu, W.3
Lu, Y.4
Lalla, E.5
Rong, L.L.6
-
12
-
-
18244381813
-
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
-
Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 2005; 25:1032-1037.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1032-1037
-
-
Falcone, C.1
Emanuele, E.2
D'Angelo, A.3
Buzzi, M.P.4
Belvito, C.5
Cuccia, M.6
-
13
-
-
21644441444
-
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
-
Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005; 7:R817-R824.
-
(2005)
Arthritis Res Ther
, vol.7
-
-
Pullerits, R.1
Bokarewa, M.2
Dahlberg, L.3
Tarkowski, A.4
-
14
-
-
33751509416
-
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
-
Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 2006; 91:4628-4634.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4628-4634
-
-
Basta, G.1
Sironi, A.M.2
Lazzerini, G.3
Del Turco, S.4
Buzzigoli, E.5
Casolaro, A.6
-
15
-
-
18844468132
-
Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: The role of modulating inflammation
-
III22-III27
-
Kereiakes DJ. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation. Circulation 2003; 108:III22-III27.
-
(2003)
Circulation
, vol.108
-
-
Kereiakes, D.J.1
-
16
-
-
2442521402
-
Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release
-
Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004; 38:517-525.
-
(2004)
Free Radic Res
, vol.38
, pp. 517-525
-
-
Berg, K.1
Wiseth, R.2
Bjerve, K.3
Brurok, H.4
Gunnes, S.5
Skarra, S.6
-
17
-
-
0031586491
-
Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
-
Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997; 350:1217-1219.
-
(1997)
Lancet
, vol.350
, pp. 1217-1219
-
-
Walter, D.H.1
Schachinger, V.2
Elsner, M.3
Dimmeler, S.4
Zeiher, A.M.5
-
18
-
-
19744379901
-
Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease
-
Lubrano V, Cocci F, Battaglia D, Papa A, Marraccini P, Zucchelli GC. Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005; 19: 110-114.
-
(2005)
J Clin Lab Anal
, vol.19
, pp. 110-114
-
-
Lubrano, V.1
Cocci, F.2
Battaglia, D.3
Papa, A.4
Marraccini, P.5
Zucchelli, G.C.6
-
19
-
-
0017018921
-
New method for determination of free amino groups in intact pure proteins: Relationship to available lysine
-
Purcell JM, Quimby DJ, Cavanaugh JR. New method for determination of free amino groups in intact pure proteins: relationship to available lysine. J Assoc Off Anal Chem 1976; 59:1251-1254.
-
(1976)
J Assoc Off Anal Chem
, vol.59
, pp. 1251-1254
-
-
Purcell, J.M.1
Quimby, D.J.2
Cavanaugh, J.R.3
-
20
-
-
18144424770
-
Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome
-
Cheneau E, Pichard AD, Satler LF, Suddath WO, Weissman NJ, Waksman R. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome. Am J Cardiol 2005; 95:1240-1242.
-
(2005)
Am J Cardiol
, vol.95
, pp. 1240-1242
-
-
Cheneau, E.1
Pichard, A.D.2
Satler, L.F.3
Suddath, W.O.4
Weissman, N.J.5
Waksman, R.6
-
21
-
-
0142089171
-
Prognostic value of myeloperoxidase in patients with chest pain
-
Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349:1595-1604.
-
(2003)
N Engl J Med
, vol.349
, pp. 1595-1604
-
-
Brennan, M.L.1
Penn, M.S.2
Van Lente, F.3
Nambi, V.4
Shishehbor, M.H.5
Aviles, R.J.6
-
22
-
-
14044264244
-
Early release of neutrophil markers of activation after direct stenting in patients with unstable angina
-
Gach O, Biemar C, Nys M, Deby-Dupont G, Chapelle JP, Deby C, et al. Early release of neutrophil markers of activation after direct stenting in patients with unstable angina. Coron Artery Dis 2005; 16:59-65.
-
(2005)
Coron Artery Dis
, vol.16
, pp. 59-65
-
-
Gach, O.1
Biemar, C.2
Nys, M.3
Deby-Dupont, G.4
Chapelle, J.P.5
Deby, C.6
-
23
-
-
33846553034
-
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease
-
Rudolph V, Steven D, Gehling UM, Goldmann B, Rudolph TK, Friedrichs K, et al. Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease. Free Radic Biol Med 2007; 42:460-465.
-
(2007)
Free Radic Biol Med
, vol.42
, pp. 460-465
-
-
Rudolph, V.1
Steven, D.2
Gehling, U.M.3
Goldmann, B.4
Rudolph, T.K.5
Friedrichs, K.6
-
24
-
-
0042915798
-
Production of N(epsilon)-(carboxymethyl) lysine is impaired in mice deficient in NADPH oxidase: A role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation
-
Anderson MM, Heinecke JW. Production of N(epsilon)-(carboxymethyl) lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes 2003; 52:2137-2143.
-
(2003)
Diabetes
, vol.52
, pp. 2137-2143
-
-
Anderson, M.M.1
Heinecke, J.W.2
-
25
-
-
33646693817
-
Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis
-
Naruko T, Ueda M, Ehara S, Itoh A, Haze K, Shirai N, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol 2006; 26:877-883.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 877-883
-
-
Naruko, T.1
Ueda, M.2
Ehara, S.3
Itoh, A.4
Haze, K.5
Shirai, N.6
-
26
-
-
0038736798
-
Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease
-
Wykretowicz A, Dziarmaga M, Szczepanik A, Guzik P, Wysocki H. Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease. Int J Cardiol 2003; 89:173-178.
-
(2003)
Int J Cardiol
, vol.89
, pp. 173-178
-
-
Wykretowicz, A.1
Dziarmaga, M.2
Szczepanik, A.3
Guzik, P.4
Wysocki, H.5
-
27
-
-
0032822303
-
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
-
Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999; 22:1543-1548.
-
(1999)
Diabetes Care
, vol.22
, pp. 1543-1548
-
-
Kilhovd, B.K.1
Berg, T.J.2
Birkeland, K.I.3
Thorsby, P.4
Hanssen, K.F.5
-
28
-
-
31644435648
-
Time course of specific AGEs during optimised glycaemic control in type 2 diabetes
-
Mentink CJ, Kilhovd BK, Rondas-Colbers GJ, Torjesen PA, Wolffenbuttel BH. Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Neth J Med 2006; 64:10-16.
-
(2006)
Neth J Med
, vol.64
, pp. 10-16
-
-
Mentink, C.J.1
Kilhovd, B.K.2
Rondas-Colbers, G.J.3
Torjesen, P.A.4
Wolffenbuttel, B.H.5
-
29
-
-
3843063285
-
Advanced glycoxidation end products in commonly consumed foods
-
Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104:1287-1291.
-
(2004)
J Am Diet Assoc
, vol.104
, pp. 1287-1291
-
-
Goldberg, T.1
Cai, W.2
Peppa, M.3
Dardaine, V.4
Baliga, B.S.5
Uribarri, J.6
-
30
-
-
0035710640
-
Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet
-
Sebekova K, Krajcoviova-Kudlackova M, Schinzel R, Faist V, Klvanova J, Heidland A. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr 2001; 40:275-281.
-
(2001)
Eur J Nutr
, vol.40
, pp. 275-281
-
-
Sebekova, K.1
Krajcoviova-Kudlackova, M.2
Schinzel, R.3
Faist, V.4
Klvanova, J.5
Heidland, A.6
-
31
-
-
0142122366
-
Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing?
-
Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J. Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing? Biochim Biophys Acta 2003; 1630:1-6.
-
(2003)
Biochim Biophys Acta
, vol.1630
, pp. 1-6
-
-
Schlueter, C.1
Hauke, S.2
Flohr, A.M.3
Rogalla, P.4
Bullerdiek, J.5
-
32
-
-
0037444761
-
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
-
Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370:1097-1109.
-
(2003)
Biochem J
, vol.370
, pp. 1097-1109
-
-
Yonekura, H.1
Yamamoto, Y.2
Sakurai, S.3
Petrova, R.G.4
Abedin, M.J.5
Li, H.6
|